Metaanalyses have reported beneficial changes in insulin sensitivity, fasting glucose, triglycerides, and LDL cholesterol, particularly in individuals with insulin resistance or metabolic syndrome [30,33]. This evidence concerns the gene INS and metabolic syndrome.